Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Other 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 2Carcinoma, Renal Cell 2Weight Loss 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Apnea Syndromes 1Sezary Syndrome 1Sarcoma 1Recurrence 1Overweight 1Obesity, Morbid 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Hypertension 1Hyperlipidemias 1Hemangioma 1Gastroesophageal Reflux 1Eczema 1Disease 1Digestive System Diseases 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Dermatitis, Atopic 1Collagen Diseases 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Urine Specimen Collection × Clear all
NCT02807129 2026-01-21

AgElOn

CHU de Reims

Phase NA Completed
296 enrolled
Tumor-Agnostic

Neoplasms

NCT05874726 2025-12-02

Biological Sample Repository for Gastrointestinal Disorders

Brigham and Women's Hospital

Active not recruiting
500 enrolled
GastrointestinalOther

Collagen Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Gastroesophageal Reflux, Hyperlipidemias, Hypertension, Neoplasms, Obesity, Obesity, Morbid, Sleep Apnea Syndromes, Weight Loss, Overweight

NCT05151341 2025-07-24

URODX-FGFR3

Institut de Cancérologie de Lorraine

Phase NA Completed
190 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡